Results for "Novartis"

Keyword scan across titles, descriptions, summaries, and tags. For interview listings, try Guest appearances.

6 results

Episodes

  • Squawk on the Street
    Intelligent Report

    11AM Hour: President Trump Meets with the President of Lebanon, Novartis CEO on Earnings & Alphabet's AI Lineup 7/21/26

    Squawk on the Street· Jul 21, 2026

    Markets shrug off rising oil as chip stocks rebound, Trump hits Canada with 50% tariffs, Novartis returns to growth, and Citi's strategist declares the Mag 7 era officially over.

    google-aiinvesting
  • Squawk on the Street
    StandardSummaries only

    11AM Hour: Exclusive Interviews with the CEOs of Biogen, Novartis & Visa 9/9/26

    Squawk on the Street· Sep 9, 2026

    Biogen CEO Christopher Viehbacher joins from the Wells Fargo Health Care Conference to discuss the company's drug pipeline and growth outlook. Then, Novartis CEO Vas Narasimhan joins after the company had its third drug …

    aiinvesting
  • Squawk on the Street
    StandardSummaries only

    11AM Hour: TD Bank's Jeff Solomon, Novartis Shares Plunge & Oil Prices on the Rise 9/8/26

    Squawk on the Street· Sep 8, 2026

    TD Bank U.S. Vice Chair Jeff Solomon joins with his outlook for the market and the broader economy. Then, Bank of America's Global Head of Commodities Francisco Blanch discusses his expectations for oil prices after fres…

    investing
  • Squawk on the Street
    StandardSummaries only

    10AM Hour: Global Bond Yields Rise, PA Governor & Chobani CEO, Novartis’ New MS Drug Trial Data 9/1/26

    Squawk on the Street· Sep 1, 2026

    Global bond yields are on the rise again, putting rates back at the center of the market conversation. Plus, new trial data from Novartis shows promise for its experimental multiple sclerosis drug. And Pennsylvania Gover…

    investing
  • Squawk on the Street
    Intelligent Report

    9am Hour: OpenAI Urges Caution, Qualcomm & Amazon Partnership, Novartis’ Drug Trial Setbacks 9/8/26

    Squawk on the Street· Sep 8, 2026

    Jim Cramer kicks off post-Labor Day with AI warnings from OpenAI's chief scientist, Qualcomm's Amazon deal, Oracle earnings ahead, and why he's still joyous about the AI industrial revolution despite the alarm bells.

    openaiinvesting
  • The Jaeden Schafer Podcast
    Intelligent Report

    Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human

    The Jaeden Schafer Podcast· Apr 15, 2026

    Zuckerberg's AI clone, Apple's smart glasses, Vercel's IPO readiness, Anthropic drama, banks testing a dangerous AI model, and a Molotov cocktail attack on Sam Altman's home.

    openaianthropic